Stockholders’ Equity and Equity Incentive Plan (Tables)

3 Months Ended

Mar. 31, 2025

Schedule of Common Stock Reserved for Future Issuance

As of March 31, 2025, the Company had the following shares of common stock reserved for future issuance under its equity incentive plan and employee share purchase plan:


Stock options outstanding			5,241,756
Restricted stock outstanding			5,979,212
Remaining shares available for future grant under 2021 Equity Incentive Plan(1)			3,943,021
Remaining shares available for future issuance under 2021 Employee Stock Purchase Plan(2)			2,528,247
Total shares of common stock reserved as of March 31, 2025			17,692,236

(1)Includes the automatic annual increase of 2,100,684 additional shares under the Company’s 2021 Equity Incentive Plan on January 1, 2025.

(2)Includes the automatic annual increase of 420,136 additional shares under the Company’s 2021 Employee Stock Purchase Plan on January 1, 2025.

Schedule of Share Repurchases

The following table presents certain information regarding shares repurchased during the periods presented:


	Three Months Ended March 31,
		2025		2024
Number of shares repurchased		708,488		702,620
Average price per share, including commissions		$	6.34	$	7.50
Total repurchase costs, including commissions (in millions)		$	4.5	$	5.3

Schedule of RSU Activity

A summary of RSU activity, excluding RSUs with performance conditions, and related information is as follows:



	RSUs Outstanding
	Number of Shares	Weighted-Average Grant Date Fair Value
Unvested balance as of December 31, 2024	5,051,759	$	8.20
Granted	1,263,325	5.80

Vested	(752,930)	9.52
Cancelled and forfeited	(300,064)	7.83
Unvested balance as of March 31, 2025	5,262,090	$	7.46

Schedule of Share-Based Compensation Expense by Line Item in the Consolidated Statements of Operations

The stock-based compensation expense by line item in the condensed consolidated statements of operations is summarized as follows (in thousands):



	Three Months Ended March 31,
		2025		2024
Cost of revenue
Subscription and other platform		$	425	$	668
Professional services		136		121
Total cost of revenue		561		789
Sales and marketing		2,147		3,058
Research and development		1,353		2,128
General and administrative		3,069		4,362
Total stock-based compensation expense		$	7,130	$	10,337

Schedule of Unrecognized Stock-Based Compensation Expenses and Weighted-Average Recognition Periods

The following table presents the unrecognized stock-based compensation expense and weighted-average recognition periods as of March 31, 2025 (in thousands, except years):


	Restricted Stock		ESPP
Unrecognized stock-based compensation expense	$	36,439	$	23
Weighted-average amortization period	1.81 years		0.12 years